Molecular profiling in the diagnosis and treatment of high grade sarcomas

Ultrastructural Pathology

Volumn 32, Issue 2, 2008, Pages 37-42

  Antonescu, Cristina R ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Gene expression; Microarray technology; Sarcoma

Indexed keywords

COMPLEMENTARY DNA; DNA; OLIGONUCLEOTIDE;

CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER GRADING; CANCER THERAPY; CLUSTER ANALYSIS; COMPARATIVE GENOMIC HYBRIDIZATION; CONFERENCE PAPER; DATA ANALYSIS; DNA MICROARRAY; GENE EXPRESSION; HUMAN; METHODOLOGY; MOLECULAR BIOLOGY; PRIORITY JOURNAL; PROGNOSIS; SARCOMA; VALIDATION STUDY;

DNA, NEOPLASM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICROARRAY ANALYSIS; RNA, NEOPLASM; SARCOMA; SOFT TISSUE NEOPLASMS;

EID: 43049100443     PISSN: 01913123     EISSN: 15210758     Source Type: Journal    
DOI: 10.1080/01913120801897174     Document Type: Conference Paper

References (19)

1. Ladanyi M, Gerald W. Expression Profiling of Human Tumors. Totowa, NY: Humana Press; 2003.
2. Ladanyi M, et al. Expression profiling of human tumors: the end of surgical pathology?. J Mol Diagn. 2001;3:92-97.
3. Sorlie T, et al. Gene expression patterns of breast carcinomas distinguish subclasses with clinical application. PNAS. 2001;98:10869-10874.
4. Perou CM, et al. Molecular portraits of human breast tumors. Nature. 2000;406:747-752.
5. Khan J, et al. Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks. Nat Med. 2001;7:673-679.
6. Nielsen TO, et al. Molecular characterization of soft tissue tumors: a gene expression study. Lancet. 2002;359:1301-1307.
7. Segal NH, et al. Classification of clear-cell sarcoma as a subtype of melanoma by genomic profiling. J Clin Oncol. 2003;21:1775-1781.
8. Segal NH, et al. Classification and subtype prediction of adult soft tissue sarcoma by functional genomics. Am J Pathol. 2003;163:691-700.
9. Antonescu CR, et al. Gene expression in gastrointestinal stromal tumors is distinguished by KIT genotype and anatomic site. Clin Cancer Res. 2004;10:3282-3290.
10. Bittner M, et al. Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature. 2000;406:536-540.
11. Allander SV, et al. Expression profiling of synovial sarcoma by cDNA microarrays: association of ERBB2, IGFBP2, and ELF3 with epithelial differentiation. Am J Pathol. 2002;161:1587-1595.
12. Baird K, et al. Gene expression profiling of human sarcomas: insights into sarcoma biology. Cancer Res. 2005;65:9226-9235.
13. Fritz B, et al. Microarray-based copy number and expression profiling in dedifferentiated and pleomorphic liposarcoma. Cancer Res. 2002;62:2993-2998.
14. Ohguri T, et al. Cytogenetic analysis of myxoid liposarcoma and myxofibrosarcoma by array-based comparative genomic hybridization. J Clin Pathol. 2006;59:978-983.
15. Heidenblad M, et al. Genomic profiling of bone and soft tissue tumors with supernumerary ring chromosomes using tiling resolution bacterial artificial chromosome microarrays. Oncogene. 2006;25:7106-7116.
16. West RB, et al. Apo D in soft tissue tumors: a novel marker for dermatofibrosarcoma protuberans. Am J Surg Pathol. 2004;28:1063-1069.
17. West RB, et al. The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status. Am J Pathol. 2004;165:107-113.
18. West RB, et al. Determination of stromal signatures in breast carcinoma. PLoS Biol. 2005;3:e187.
19. Terry J, et al. TLE1 as a diagnostic immunohistochemical marker for synovial sarcoma emerging from gene expression profiling studies. Am J Surg Pathol. 2007;31:240-246.